So Kyle Bass and his Coalition for Affordable Drugs have been handed a defeat in their first PTAB final written decision. See Coalition for Affordable Drugs II LLC v. Cosmo Techs Ltd. (IPR2015-00988, Paper 55). The merits of the case aside, the biggest question in my mind is: can the Coalition appeal?
On the face of things, the answer appears to be yes. … More
In Silicon Laboratories v. Cresta (IPR2014-00809), both parties relied heavily upon expert testimony to construe key claim terms. Petitioner Silicon Laboratories proffered an expert Declaration with their Petition and second expert Declaration (same expert) with their Reply. The Patent Owner, Cresta Technology, filed an expert Declaration with their Response. Both experts were deposed and the deposition transcripts were submitted as evidence.… More
A patent owner does not deprive a petitioner of standing in a covered business method (“CBM”) patent review by disclaiming the claim directed to a financial product or service.
In the final written decision for J.P. Morgan Chase & Co. v. Intellectual Ventures II LLC, CBM2014-00157, Paper 40 (Jan. 12, 2016), the PTAB determined the Petitioner had standing on the basis that at least one claim was directed to a method for performing data processing used in the practice of a financial product or service.… More